Bioverge, Inc.

Bioverge, Inc.

Comments

In a deal just announced this week, Bioverge portfolio company Volumetric has entered into an agreement for acquisition by 3D Systems (NASDAQ: DDD).

We could not be more thrilled for the Volumetric team and for participating Bioverge investors on the successful exit!

​​We first met Volumetric co-founders Jordan and Bagrat...

https://bioverge.com/blog/volumetric-to-be-acquired-by-3d-systems

#3dbioprinting #regenerativemedicine #techbio #healthtech #innnovation
Over 15,000 people are registered on the waiting list for a liver transplant, but an additional ~200,000 people have later stage disease and are not currently on the waiting list. While only 3% of these individuals are able to receive a transplant, Hepatx's revolutionary solution has the potential to be an effective cell therapy platform for liver disease.

#biotech #healthsciences #healthtech #startups
BioRosa has developed an AI-enabled blood test for the early diagnosis of Autism.

Autism Spectrum Disorder (ASD) is the largest pediatric neurodevelopmental disorder in the world and affects an estimated 1 in 54 children in the U.S. and 3% of children worldwide. With early diagnosis and treatment, health-related costs of Autism could be dramatically decreased.

#biotech #healthsciences #healthtech #startups
Pleased to share our CEO Neil Littman's latest Forbes Finance Council article, "Myth-busting in Equity Crowdfunding".

What do you think are the top myths (or obstacles) to companies pursing a #RegCF offering?

https://hubs.la/H0YXT_d0
On this week's podcast, Lindy Morris Fishburne, Managing Partner of Breakout Ventures, sits down with Neil Littman to discuss investing in seed-and early-stage bioscience companies, and what she learned working with entrepreneurial scientists at Breakout Labs.

Available on SoundCloud: https://hubs.la/H0XnMsW0

Available on iTunes: https://hubs.la/H0XnGMM0
Did you know that for a limited time we're offering our supporters an ownership stake in our growth?

If you believe in what we’re building and want to come along with us, we’d love for you to join our mission and help bring science fiction to life!

Learn more on our offering page via Netcapital here: https://hubs.la/H0XczqX0

#TechBio #regcf #equitycrowdfunding #fintech
On the latest episode of the Bioverge Podcast, Neil Littman sits down with Eric Topol, MD, Founder and Director of the Scripps Research Translational Institute, to discuss the COVID-19 delta variant, why it's such a formidable adversary, and what steps need to be taken to combat the ongoing pandemic.

https://hubs.la/H0VxDbm0
The capabilities of regenerative medicine are growing at a staggering rate. Fueled by an influx of biotechnology talent and investment capital, imagined feats like lab-grown human organs are now within reach and promise to impact the lives of countless patients and families over the next decade. With so much innovation at the forefront of medicine, it is exciting to wonder where regenerative medicine will take us next. Swipe to learn more —>

#biotech #healthsciences #healthtech #stemcells #transplants #startups
On the latest podcast, Juan Scarlett, MD of One Valley Ventures, discusses their efforts to democratize #entrepreneurship and his approach investing in early-stage #venture #vc
https://hubs.la/H0Rsc2x0
What an exciting way to end the week! We have reached $200K in investments for Bioverge on Netcapital!

We are proud to reach this milestone and thank each and every one of you for your participation in our raise.

Join our community of investors today at the link below so you can help make a difference in the lives of people across the world! 👇

https://netcapital.com/companies/bioverge

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine
Storytelling connects us, helps us make sense of the world, communicates our values and beliefs, and sparks conversations.

Stories connect us to our communities.

Today, our Co-Founder Neil Littman shares with you his personal story that inspired him to start Bioverge. Click to listen 🎧 👉 https://www.youtube.com/watch?v=Jbaf6hDks_A

Share your story with us 👇

Join Bioverge’s Netcapital community at https://netcapital.com/companies/bioverge?utm_source=facebook&utm_medium=captions&utm_campaign=dna

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine
Yes! 🙌

Our Co-Founder, Neil Littman, started his career in healthcare investment banking and had the opportunity to work on both public and private financings, including IPOs!

Neil's prior experience makes him uniquely positioned to guide Bioverge to success!

Questions about our investment opportunity? Leave them on Netcapital https://netcapital.com/companies/bioverge/ask-a-question! Neil will get back to you shortly!

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

Bioverge is an investment platform that funds visionary entrepreneurs who are transforming healthcare and bringing science fiction to life. Sign up today at bioverge.com and see how you can make an impact!

Operating as usual

11/03/2021

In a deal just announced this week, Bioverge portfolio company Volumetric has entered into an agreement for acquisition by 3D Systems (NASDAQ: DDD).

We could not be more thrilled for the Volumetric team and for participating Bioverge investors on the successful exit!

​​We first met Volumetric co-founders Jordan and Bagrat...

https://bioverge.com/blog/volumetric-to-be-acquired-by-3d-systems

#3dbioprinting #regenerativemedicine #techbio #healthtech #innnovation

Photos from Bioverge, Inc.'s post 10/25/2021

Over 15,000 people are registered on the waiting list for a liver transplant, but an additional ~200,000 people have later stage disease and are not currently on the waiting list. While only 3% of these individuals are able to receive a transplant, Hepatx's revolutionary solution has the potential to be an effective cell therapy platform for liver disease.

#biotech #healthsciences #healthtech #startups

Photos from Bioverge, Inc.'s post 10/15/2021

BioRosa has developed an AI-enabled blood test for the early diagnosis of Autism.

Autism Spectrum Disorder (ASD) is the largest pediatric neurodevelopmental disorder in the world and affects an estimated 1 in 54 children in the U.S. and 3% of children worldwide. With early diagnosis and treatment, health-related costs of Autism could be dramatically decreased.

#biotech #healthsciences #healthtech #startups

Council Post: Myth-Busting In Equity Crowdfunding 10/06/2021

Council Post: Myth-Busting In Equity Crowdfunding

Pleased to share our CEO Neil Littman's latest Forbes Finance Council article, "Myth-busting in Equity Crowdfunding".

What do you think are the top myths (or obstacles) to companies pursing a #RegCF offering?

https://hubs.la/H0YXT_d0

Council Post: Myth-Busting In Equity Crowdfunding With these new regulatory changes and the strong increase recently in equity crowdfunding activity, now’s a perfect time to dispel some myths about the sector.

Investing in the Bio-Based Future 09/15/2021

Investing in the Bio-Based Future

On this week's podcast, Lindy Morris Fishburne, Managing Partner of Breakout Ventures, sits down with Neil Littman to discuss investing in seed-and early-stage bioscience companies, and what she learned working with entrepreneurial scientists at Breakout Labs.

Available on SoundCloud: https://hubs.la/H0XnMsW0

Available on iTunes: https://hubs.la/H0XnGMM0

Investing in the Bio-Based Future Lindy Fishburne, managing partner of Breakout Ventures, sits down with Neil to discuss investing in seed- and early-stage bioscience companies, and what she learned working with entrepreneurial scient

Timeline Photos 09/14/2021

Did you know that for a limited time we're offering our supporters an ownership stake in our growth?

If you believe in what we’re building and want to come along with us, we’d love for you to join our mission and help bring science fiction to life!

Learn more on our offering page via Netcapital here: https://hubs.la/H0XczqX0

#TechBio #regcf #equitycrowdfunding #fintech

Did you know that for a limited time we're offering our supporters an ownership stake in our growth?

If you believe in what we’re building and want to come along with us, we’d love for you to join our mission and help bring science fiction to life!

Learn more on our offering page via Netcapital here: https://hubs.la/H0XczqX0

#TechBio #regcf #equitycrowdfunding #fintech

Evolving Failures in an Evolving Pandemic and What Needs to Be Done 08/18/2021

Evolving Failures in an Evolving Pandemic and What Needs to Be Done

On the latest episode of the Bioverge Podcast, Neil Littman sits down with Eric Topol, MD, Founder and Director of the Scripps Research Translational Institute, to discuss the COVID-19 delta variant, why it's such a formidable adversary, and what steps need to be taken to combat the ongoing pandemic.

https://hubs.la/H0VxDbm0

Evolving Failures in an Evolving Pandemic and What Needs to Be Done Eric Topol, founder and director of the Scripps Research Translational Institute, sits down with Neil to discuss the COVID-19 delta variant, our failures to evolve with the virus, and what steps need

Photos from Bioverge, Inc.'s post 08/11/2021

The capabilities of regenerative medicine are growing at a staggering rate. Fueled by an influx of biotechnology talent and investment capital, imagined feats like lab-grown human organs are now within reach and promise to impact the lives of countless patients and families over the next decade. With so much innovation at the forefront of medicine, it is exciting to wonder where regenerative medicine will take us next. Swipe to learn more —>

#biotech #healthsciences #healthtech #stemcells #transplants #startups

Democratizing Entrepreneurship 07/02/2021

Democratizing Entrepreneurship

On the latest podcast, Juan Scarlett, MD of One Valley Ventures, discusses their efforts to democratize #entrepreneurship and his approach investing in early-stage #venture #vc
https://hubs.la/H0Rsc2x0

Democratizing Entrepreneurship Juan Scarlett, managing director of OneValley Ventures, sits down with Neil to discusses OneValley's efforts to democratize entrepreneurship and his approach investing in pre-seed and seed funding rou

Timeline Photos 06/24/2021

What an exciting way to end the week! We have reached $200K in investments for Bioverge on Netcapital!

We are proud to reach this milestone and thank each and every one of you for your participation in our raise.

Join our community of investors today at the link below so you can help make a difference in the lives of people across the world! 👇

https://netcapital.com/companies/bioverge

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

What an exciting way to end the week! We have reached $200K in investments for Bioverge on Netcapital!

We are proud to reach this milestone and thank each and every one of you for your participation in our raise.

Join our community of investors today at the link below so you can help make a difference in the lives of people across the world! 👇

https://netcapital.com/companies/bioverge

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

Why I Founded Bioverge: My Mission to Democratize Healthcare Investment Opportunities 06/22/2021

Why I Founded Bioverge: My Mission to Democratize Healthcare Investment Opportunities

Storytelling connects us, helps us make sense of the world, communicates our values and beliefs, and sparks conversations.

Stories connect us to our communities.

Today, our Co-Founder Neil Littman shares with you his personal story that inspired him to start Bioverge. Click to listen 🎧 👉 https://www.youtube.com/watch?v=Jbaf6hDks_A

Share your story with us 👇

Join Bioverge’s Netcapital community at https://netcapital.com/companies/bioverge?utm_source=facebook&utm_medium=captions&utm_campaign=dna

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

Why I Founded Bioverge: My Mission to Democratize Healthcare Investment Opportunities Fireside Chat w Bioverge CEO Neil Littman

Timeline Photos 06/18/2021

Yes! 🙌

Our Co-Founder, Neil Littman, started his career in healthcare investment banking and had the opportunity to work on both public and private financings, including IPOs!

Neil's prior experience makes him uniquely positioned to guide Bioverge to success!

Questions about our investment opportunity? Leave them on Netcapital https://netcapital.com/companies/bioverge/ask-a-question! Neil will get back to you shortly!

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

Yes! 🙌

Our Co-Founder, Neil Littman, started his career in healthcare investment banking and had the opportunity to work on both public and private financings, including IPOs!

Neil's prior experience makes him uniquely positioned to guide Bioverge to success!

Questions about our investment opportunity? Leave them on Netcapital https://netcapital.com/companies/bioverge/ask-a-question! Neil will get back to you shortly!

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

06/16/2021

Bioverge is Bringing Science Fiction to Life

Invest in the future of healthcare today, for a healthier tomorrow 💙

https://netcapital.com/companies/bioverge

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

06/16/2021

Meet our PR and Corporate Communications Advisor Janine McCargo!

Say hi to Janine McCargo, Bioverge's Public Relations and Corporate Communications Advisor! 👋

Twenty years of agency experience in corporate communications, the last 16 spent providing strategic counsel and tactical ex*****on to biopharma and medtech companies ranging from VC-funded startups to emerging publicly traded firms and global organizations.

Learn more about our diverse and multi-disciplinary team on Netcapital https://netcapital.com/companies/bioverge

#startups #funding #regcf #bioverge #healthcare #health #medicine

Council Post: Healthcare-Focused Impact Investing: Another Way To Invest For Change 06/15/2021

Council Post: Healthcare-Focused Impact Investing: Another Way To Invest For Change

We're firm believers that making a difference and achieving returns are not mutually exclusive.

Rather, everyday people can induce change through impact investing--a movement that's grown rapidly since first coined in 2007 by the Rockefeller Foundation.

We'll let our Co-Founder and CEO Neil Littman explain in his Forbes article.

https://www.forbes.com/sites/forbesfinancecouncil/2021/04/28/healthcare-focused-impact-investing-another-way-to-invest-for-change/?sh=37c1ef301e5c

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

Council Post: Healthcare-Focused Impact Investing: Another Way To Invest For Change Healthcare provides another avenue in which investors can do well by doing good.

Timeline Photos 06/11/2021

Thank you Suggestic for the kind words! We look forward to seeing how our partnership will continue to be fruitful!

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

Thank you Suggestic for the kind words! We look forward to seeing how our partnership will continue to be fruitful!

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

06/10/2021

The Market Opportunity of Equity Crowdfunding

According to the SEC, the private placements market was $1.8 trillion in 2017 as roughly 300,000 accredited investors participated in 23,000 offerings. In 2019, the market grew to $2.7 trillion (+25% CAGR). 📈

Equity crowdfunding is gaining momentum fast, and we look forward to capitalizing on this as the market continues to grow.

Join the momentum today as an investor in Bioverge on Netcapital https://netcapital.com/companies/bioverge

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

06/10/2021

Questions Bioverge gets from Investors on Netcapital

The Bioverge campaign is live and currently accepting investments!

Prior to launching our equity crowdfunding platform in April '21, we built a successful online venture capital platform that has closed 36 deals across a portfolio of 25 companies, and counting.

The portfolio companies we have invested in under this model--which we will continue to operate--have received funding from premier venture firms including: Andreessen Horowitz, Thiel Capital, NEA, First Round Capital. Lightspeed Venture Partners, Greylock Partners, Polaris Partners, Social Capital, Khosla Ventures, Founders Fund, Amgen Ventures, and Y Combinator.

Check out the Bioverge raise page on Netcapital to learn more: https://netcapital.com/companies/bioverge

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

06/08/2021

Bioverge Featured on MedTech Strategist!

Have you seen the profile of Bioverge by MedTech Strategist? 🤔

If not, don't sweat it! You can read the full article here. 👇

https://www.mystrategist.com/medtech-strategist/article/bioverge_fills_an_early-stage_funding_gap_while_democratizing_private_investing_.html

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

06/03/2021

Listend to our founder Neil Littman on the Meb Faber Show!

Bioverge founder, Neil Littman, was a guest on the Meb Faber Show to talk about the Bioverge platform. 👌

Listen to the full chat with Meb Faber here!👇

https://mebfaber.com/2019/03/13/episode-146-neil-littman-the-more-risk-you-kill-inherently-the-more-value-you-create/

#equitycrowdfunding #funding #regcf #bioverge #healthcare #health #medicine

06/02/2021

Our Investment Platform is Truly Unique

An investment in Bioverge means more capital for innovators whose discoveries can improve and lengthen the lives of patients around the world. 💙 🌎

Invest in Bioverge today on Netcapital 👉 https://netcapital.com/companies/bioverge

#bioverge #healthcare #netcapital #equitycrowdfunding #regcf #startups

Advancing a Pipeline of Off-The-Shelf Cell Therapies 06/01/2021

Advancing a Pipeline of Off-The-Shelf Cell Therapies

On our latest podcast, we sit down w/ @CEO_Culley of @LineageCell to discuss the development of allogenic cell therapies to treat degenerative retinal disease, spinal cord injury, and cancer.

https://hubs.la/H0Pmy1H0

Advancing a Pipeline of Off-The-Shelf Cell Therapies Brian Culley, CEO of Lineage Cell Therapeutics, sits down with Neil to discuss his company’s efforts to develop off-the-shelf cell therapies to treat degenerative retinal disease, spinal cord injury,

05/28/2021

Our Mission

Everyone deserves the opportunity to invest in the future of #healthcare. ⚕️💸

Not only for democratized access, but to have the opportunity to make a long-term difference in our lives and the lives of others. 💙

Join our mission today as an #investor in the Bioverge platform on Netcapital !

#equitycrowdfunding #RegCF

05/27/2021

Meet Rick!

Say hey to our co-founder Rick! 👋

We're firm believers that with Rick's 🧠 on our team, the issuers on our platform can achieve more success! 🙌 Check out his incredible experience. 👇

💰 He was an investment and commercialization professional at Stanford, where he managed $450M across 2 venture capital funds and maintained a portfolio of 300+ healthcare inventions

🌲 Prior to founding Bioverge, Rick worked at Stanford University’s Office of the CFO as a Senior Venture Fund Analyst where he was involved in the management and oversight of the President’s Venture Fund and Stanford-StartX Fund

🔬 Rick holds a Master’s Degree in Biotechnology from The Johns Hopkins University, and graduated from Rice University with a B.S. in Bioengineering and Biomedical Engineering

Investors, learn more about the rest of our team of visionaries on our Netcapital page! https://bit.ly/3fCGd6D

#equitycrowdfunding #netcapital #healthcare #RegCF #funding #entrepreneurs #startups

05/27/2021

Meet Matt De Silva!

Kind words from founders always make our day. 😊 Thank you Matt De Silva!
Join our investor community today on Netcapital
https://bit.ly/3fCGd6D

#equitycrowdfunding #netcapital #healthcare #RegCF #funding #entrepreneurs #startups

05/25/2021

Bioverge Has Raised $165K+ on Netcapital!

We're excited to hit this milestone so early in our Netcapital campaign! 🙌

Thank you to everyone that has made it possible! https://netcapital.com/companies/bioverge

#bioverge #healthcare #netcapital #equitycrowdfunding #regcf #startups

05/24/2021

Bioverge's Success to Date

We're proud to have achieved these milestones so early on and are just getting started! 🎉 🏆

A BIG thank you to everyone, especially our company founders and investors that make it possible. 😊

We wouldn't be here without you!

https://netcapital.com/companies/bioverge

#bioverge #equitycrowdfunding #netcapital #healthcare #regcf #funding #entrepreneurs #startups

05/22/2021

Bioverge Wins Second Place in Fintech50 2021!

In case you missed it...

Bioverge finished 2nd in TechRound's Fintech50 for 2021! 🎉

We're so proud to have this honor, and hope to earn more mentions, press, and awards as we continue to develop Bioverge on our mission to increase investment opportunities to innovative healthcare startups.

Check out our other notable awards on @netcapital https://netcapital.com/companies/bioverge

#equitycrowdfunding #bioverge #funding #RegCF #healthcare

Timeline Photos 05/21/2021

A strong leadership team is one of the top reasons why investors back startups, and we're proud to have Neil Littman (@njlittman), as a visionary behind Bioverge.

Some fun facts about Neil:

✔️ Neil was previously Vice President of Business Development at @NotableLabs, an oncology focused startup

✔️ Prior to Notable, Neil was a member of the Executive Leadership Team and Director of Business Development at the California Institute for Regenerative Medicine (CIRM).

✔️ At CIRM, Neil was Head of the Therapeutics Group and oversaw a team responsible for managing over 40 clinical stage therapies totaling over $500 million of CIRM investment

Neil has an impressive track record, we can't fit it all in this caption! Learn more about his successes on our @Netcaptial page https://netcapital.com/companies/bioverge

#equitycrowdfunding #netcapital #healthcare #RegCF #funding #entrepreneurs #startups

A strong leadership team is one of the top reasons why investors back startups, and we're proud to have Neil Littman (@njlittman), as a visionary behind Bioverge.

Some fun facts about Neil:

✔️ Neil was previously Vice President of Business Development at @NotableLabs, an oncology focused startup

✔️ Prior to Notable, Neil was a member of the Executive Leadership Team and Director of Business Development at the California Institute for Regenerative Medicine (CIRM).

✔️ At CIRM, Neil was Head of the Therapeutics Group and oversaw a team responsible for managing over 40 clinical stage therapies totaling over $500 million of CIRM investment

Neil has an impressive track record, we can't fit it all in this caption! Learn more about his successes on our @Netcaptial page https://netcapital.com/companies/bioverge

#equitycrowdfunding #netcapital #healthcare #RegCF #funding #entrepreneurs #startups

Videos (show all)

Bioverge is Bringing Science Fiction to Life
Meet our PR and Corporate Communications Advisor Janine McCargo!
The Market Opportunity of Equity Crowdfunding
Questions Bioverge gets from Investors on Netcapital
Bioverge Featured on MedTech Strategist!
Listend to our founder Neil Littman on the Meb Faber Show!
Our Investment Platform is Truly Unique
Our Mission
Meet Rick!
Meet Matt De Silva!
Bioverge Has Raised $165K+ on Netcapital!

Telephone

Address


237 Kearny Street #9171
San Francisco, CA
94108
Other Medical & Health in San Francisco (show all)
Toland Medical College Toland Medical College
San Francisco

Grand Rounds Health Grand Rounds Health
San Francisco

We build a personal care team shaped around you to make sure you get the best possible healthcare. From finding you top doctors in your network, to providing expert medical opinions, to explaining your health benefits and more - we’re here to help 24/7.

The Doctor's Spicebox - Thrive Kitchen Cooking Classes The Doctor's Spicebox - Thrive Kitchen Cooking Classes
Kaiser Permanente San Francisco, 1600 Owens St,
San Francisco, 94158

The Doctor's Spicebox offers fun, hands-on cooking classes w/flavors from around the world. Improve your cooking and your health! W/ Chef Linda Shiue, MD.

University of San Francisco School of Nursing & Health Professions University of San Francisco School of Nursing & Health Professions
2130 Fulton St
San Francisco, 94117

Founded in 1954, The University of San Francisco's School of Nursing and Health Professions is in the heart of one of the world’s most innovative and diverse cities and is a vibrant academic community of students and faculty of healthcare.

Amino Amino
San Francisco

Amino's digital healthcare guidance platform provides a fast, easy way to search for providers, book appointments, and access employer-sponsored health benefits.

Nikolai's Therapeutic Bodywork Nikolai's Therapeutic Bodywork
6527 Geary Blvd., St Suite 3 San Francisco, CA 94121
San Francisco, 94121

Spine Alignment For Immediate Pain Relief

Claims Plus Insurance Solutions Claims Plus Insurance Solutions
306 Baden St
San Francisco, 94131

We at CPIS are Health Insurance brokers who want to help you find the best health plan for you, your family and/or staff. We take the time to ensure you understand your policy so you do not have any hidden surprises when you are ill or in an accident.

Mighty Breed Mighty Breed
San Francisco

MIGHTY BREED works hard to provide top of the line medicinal cannabis and excellent delivery service to enhance the lives of our patients.

San Francisco Surgery Center San Francisco Surgery Center
450 Sutter St Rm 1130
San Francisco, 94108

Roam Robotics Roam Robotics
650 Alabama Street
San Francisco, 94110

Roam Robotics is dedicated to helping millions of people push past their current physical boundaries and extend their ability to do the activities they love.

BusTest Express BusTest Express
300 Toland Street
San Francisco, 94124

First-of-its-kind self-contained mobile medical testing and treatment motorcoaches that can offer CO

Donald C. Bliss, LCSW Donald C. Bliss, LCSW
2215 Market St, # 422
San Francisco, 94114